Results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injection

<p><strong>Foundation</strong>: Cystic thyroid nodules, usually benign, can cause clinical symptoms. Percutaneous ethanol injection is recognized as first-line treatment for thyroid cysts and nodules with a predominant liquid component.<br /><strong>Objective</strong...

Full description

Saved in:
Bibliographic Details
Main Authors: Lázaro Lorda Galiano, Jacinto Oscar Navas Igarza
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2024-11-01
Series:Medisur
Subjects:
Online Access:http://medisur.sld.cu/index.php/medisur/article/view/45267
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576868669194240
author Lázaro Lorda Galiano
Jacinto Oscar Navas Igarza
author_facet Lázaro Lorda Galiano
Jacinto Oscar Navas Igarza
author_sort Lázaro Lorda Galiano
collection DOAJ
description <p><strong>Foundation</strong>: Cystic thyroid nodules, usually benign, can cause clinical symptoms. Percutaneous ethanol injection is recognized as first-line treatment for thyroid cysts and nodules with a predominant liquid component.<br /><strong>Objective</strong>: To describe the results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injection.<br /><strong>Methods</strong>: A descriptive study was conducted in patients with benign nodular goiter and cystic and predominantly cystic dominant nodules, treated with percutaneous ethanol injection. Categorical variables were described by absolute frequencies and percentages; and for the numerical ones the mean and standard deviation were calculated. The changes between the initial and final volumes of the nodules were evaluated using the Student t test for related samples.<br /><strong>Results</strong>: 12 months after the treatment, the percentage reduction in the volume of the nodules behaved as follows: mean 92.50 ± 5.5 minimum 81.0 and maximum 99.8. Clinical success was complete in 100% of the patients, as was the efficacy of the technique. The only adverse effect was burning in 2 patients (8.33%). No patient presented complications during the study.<br /><strong>Conclusions</strong>: Treatment with percutaneous ethanol injection in patients with nodular goiter and cystic or predominantly cystic dominant thyroid nodules is safe and effective, with transient adverse effects and a very low rate of complications.</p>
format Article
id doaj-art-f667be7bcf7a408b970ead49b1c55c3e
institution Kabale University
issn 1727-897X
language Spanish
publishDate 2024-11-01
publisher Centro Provincial de Información de Ciencias Médicas. Cienfuegos
record_format Article
series Medisur
spelling doaj-art-f667be7bcf7a408b970ead49b1c55c3e2025-01-30T21:29:03ZspaCentro Provincial de Información de Ciencias Médicas. CienfuegosMedisur1727-897X2024-11-01226104410502568Results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injectionLázaro Lorda Galiano0Jacinto Oscar Navas Igarza1Hospital Militar Central Dr. Carlos J. Finlay. La HabanaHospital Militar Central Dr. Carlos J. Finlay. La Habana<p><strong>Foundation</strong>: Cystic thyroid nodules, usually benign, can cause clinical symptoms. Percutaneous ethanol injection is recognized as first-line treatment for thyroid cysts and nodules with a predominant liquid component.<br /><strong>Objective</strong>: To describe the results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injection.<br /><strong>Methods</strong>: A descriptive study was conducted in patients with benign nodular goiter and cystic and predominantly cystic dominant nodules, treated with percutaneous ethanol injection. Categorical variables were described by absolute frequencies and percentages; and for the numerical ones the mean and standard deviation were calculated. The changes between the initial and final volumes of the nodules were evaluated using the Student t test for related samples.<br /><strong>Results</strong>: 12 months after the treatment, the percentage reduction in the volume of the nodules behaved as follows: mean 92.50 ± 5.5 minimum 81.0 and maximum 99.8. Clinical success was complete in 100% of the patients, as was the efficacy of the technique. The only adverse effect was burning in 2 patients (8.33%). No patient presented complications during the study.<br /><strong>Conclusions</strong>: Treatment with percutaneous ethanol injection in patients with nodular goiter and cystic or predominantly cystic dominant thyroid nodules is safe and effective, with transient adverse effects and a very low rate of complications.</p>http://medisur.sld.cu/index.php/medisur/article/view/45267bocio nodularinyeccionesterapéuticaetanol
spellingShingle Lázaro Lorda Galiano
Jacinto Oscar Navas Igarza
Results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injection
Medisur
bocio nodular
inyecciones
terapéutica
etanol
title Results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injection
title_full Results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injection
title_fullStr Results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injection
title_full_unstemmed Results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injection
title_short Results of the cystic and predominantly cystic thyroid nodules’ treatment by percutaneous ethanol injection
title_sort results of the cystic and predominantly cystic thyroid nodules treatment by percutaneous ethanol injection
topic bocio nodular
inyecciones
terapéutica
etanol
url http://medisur.sld.cu/index.php/medisur/article/view/45267
work_keys_str_mv AT lazarolordagaliano resultsofthecysticandpredominantlycysticthyroidnodulestreatmentbypercutaneousethanolinjection
AT jacintooscarnavasigarza resultsofthecysticandpredominantlycysticthyroidnodulestreatmentbypercutaneousethanolinjection